drugset / Trial / NCT06760195

Intra-arterial Hypothermic Magnesium Sulfate Infusion in Combination with Endovascular Thrombectomy in Acute Ischemic Stroke

NCT06760195

Phase 0 Not yet recruiting 6 enrolled Capital Medical University
NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study is to estimate the safety of intra-arterial hypothermic magnesium sulfate infusion after endovascular thrombectomy in patients with acute ischemic stroke

Timeline

Start
2025-01-10
Primary completion
2025-06-30
Completion
2025-06-30

Drugs

EvaluationDrugModalityDoseRoute
Background Alteplase Protein / enzyme biologic 0.9 mg/kg Intravenous

Indications